VYM Fails To Medal In The High Dividend Event
When you qualify for an Olympic event, you are one of the best. To win the Gold medal, you…
Kroger: Contrarian Play With Upside In Digital
Strong play in digital sales at a reasonable valuation.
Cognition Therapeutics: Targeting S2R For Age-Related Degenerative Diseases
CGTX is targeting the S2R complex for the treatment of age-related degenerative diseases. The company is looking to raise…
Is It Time To Sell Stocks And Bonds? Perhaps, But Timing The Market Is A Fool’s Errand.
With stocks and bonds at historically high valuations and low yields, many investments are offering negative real returns. Read…
The S&P 500 High Beta ETF: Here’s How To Trade It
The Invesco S&P 500 High Beta ETF selects the top 100 most sensitive stocks in the S&P 500 over…
How I’m Building A Tax-Free Portfolio With 8% Yields And Double-Digit Total Returns
CEFs continue to provide an advantage over most open-end and passive options. Read more about our “buy-and-rent” approach of…
Skillz: User Growth Problems
Skillz is still expensive due to a lack of user growth while aggressively spending on marketing. Here’s why I…
Stock market looking to move past Delta variant as companies implement new rules
Companies are taking the lead in adopting mask and vaccine requirements as COVID Delta cases grow and equities remain…
EchoStar Corporation (SATS) Management Presents on Q2 2021 Results – Earnings Call Transcript
EchoStar Corporation (NASDAQ:SATS) Q2 2021 Earnings Conference Call August 3, 2021 11:00 AM ETCompany ParticipantsTerry Brown…
Gilead Oncology Franchise Adding To Growth Scenario
Gilead’s Q2 y/y growth was largely driven by Veklury revenue. Oncology revenue is also ramping, up 90% y/y. Read…
recent post
-
Nov 16 2025 -
-
Nov 16 2025
-
Nov 16 2025
-
Nov 16 2025
